-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Vitaspring Biomedical Co. Ltd. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q1 2017 to Q3 2022.
- Vitaspring Biomedical Co. Ltd. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending October 31, 2022 was $4.47K.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)